Skip Navigation


Brain Advance Access originally published online on May 30, 2008
Brain 2008 131(7):1749-1758; doi:10.1093/brain/awn096
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow An erratum has been published
Right arrow An erratum has been published
Right arrow All Versions of this Article:
131/7/1749    most recent
awn096v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in Brain
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Kuhlmann, T.
Right arrow Articles by Brück, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kuhlmann, T.
Right arrow Articles by Brück, W.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author (2008). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis

T. Kuhlmann1,2, V. Miron3, Q. Cuo3, C. Wegner2, J. Antel3 and W. Brück2,4

1Institute of Neuropathology, University Hospital Münster, Münster, Germany, 2Department of Neuropathology, University Medical Centre Göttingen, 3Neuroimmunology Unit, Montreal Neurological Institute, McGill University, Montreal, Canada and 4Institute for Multiple Sclerosis Research, University Medical Centre Göttingen and Gemeinnützige Hertie-Stiftung, Göttingen, Germany

Correspondence to: Tanja Kuhlmann, Institute of Neuropathology, University Hospital Münster, Münster, Domagkstr. 19, 48149 Münster, Germany E-mail: tanjakuhlmann{at}gmx.de

Impaired function/differentiation of progenitor cells might provide an explanation for the limited remyelination observed in the majority of chronic multiple sclerosis lesions. Here, we establish that in the normal adult human CNS, the transcription factors Nkx2.2 and Olig2 are strongly expressed in progenitor cells while mature oligodendrocytes are characterized by low levels of Olig2 or Nkx2.2. In vitro studies confirmed the expression of Olig2 in oligodendroglial progenitor cells and mature oligodendrocytes while astrocytes, microglial cells and neurons were negative for Olig2. In early multiple sclerosis lesions, we found Olig2-positive progenitor cells throughout all lesion stages and in periplaque white matter (PPWM). The number of progenitors in PPWM was significantly increased compared with the white matter from controls. In chronic multiple sclerosis lesions progenitor cells were still present, however, in significantly lower numbers than in early multiple sclerosis lesions. A subpopulation of progenitor cells in early multiple sclerosis lesions and PPWM but not in control cases co-expressed NogoA, a marker of mature oligodendrocytes. The co-expression of these two markers suggested that these cells were maturing oligodendrocytes recently recruited from the progenitor pool. In contrast, in chronic multiple sclerosis lesions maturing progenitors were only rarely present. In summary, we provide evidence that a differentiation block of oligodendroglial progenitors is a major determinant of remyelination failure in chronic multiple sclerosis lesions.

Key Words: oligodendroglial progenitors; multiple sclerosis; Olig2; Nkx2.2

Abbreviations: OPCs, oligodendroglial progenitor cells; PPWM, periplaque white matter

Received December 5, 2007. Revised April 15, 2008. Accepted April 25, 2008.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related articles in Brain:

Editorial
Alastair Compston
Brain 2008 131: 1675-1676. [Extract] [FREE Full Text]  



This article has been cited by other articles:


Home page
 Genes Dev.Home page
S. P.J. Fancy, S. E. Baranzini, C. Zhao, D.-I. Yuk, K.-A. Irvine, S. Kaing, N. Sanai, R. J.M. Franklin, and D. H. Rowitch
Dysregulation of the Wnt pathway inhibits timely myelination and remyelination in the mammalian CNS
Genes & Dev., July 1, 2009; 23(13): 1571 - 1585.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
D. Kremer, A. Heinen, J. Jadasz, P. Gottle, K. Zimmermann, P. Zickler, S. Jander, H.-P. Hartung, and P. Kury
p57kip2 is dynamically regulated in experimental autoimmune encephalomyelitis and interferes with oligodendroglial maturation
PNAS, June 2, 2009; 106(22): 9087 - 9092.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
T. Goldschmidt, J. Antel, F. B. Konig, W. Bruck, and T. Kuhlmann
Remyelination capacity of the MS brain decreases with disease chronicity
Neurology, June 2, 2009; 72(22): 1914 - 1921.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
A. Melani, S. Cipriani, M. G. Vannucchi, D. Nosi, C. Donati, P. Bruni, M. G. Giovannini, and F. Pedata
Selective adenosine A2a receptor antagonism reduces JNK activation in oligodendrocytes after cerebral ischaemia
Brain, June 1, 2009; 132(6): 1480 - 1495.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
V. E. Miron, S. P. Zehntner, T. Kuhlmann, S. K. Ludwin, T. Owens, T. E. Kennedy, B. J. Bedell, and J. P. Antel
Statin Therapy Inhibits Remyelination in the Central Nervous System
Am. J. Pathol., May 1, 2009; 174(5): 1880 - 1890.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
R. Pescini Gobert, L. Joubert, M.-L. Curchod, C. Salvat, I. Foucault, C. Jorand-Lebrun, M. Lamarine, H. Peixoto, C. Vignaud, C. Fremaux, et al.
Convergent Functional Genomics of Oligodendrocyte Differentiation Identifies Multiple Autoinhibitory Signaling Circuits
Mol. Cell. Biol., March 15, 2009; 29(6): 1538 - 1553.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
A. S. Baer, Y. A. Syed, S. U. Kang, D. Mitteregger, R. Vig, C. ffrench-Constant, R. J. M. Franklin, F. Altmann, G. Lubec, and M. R. Kotter
Myelin-mediated inhibition of oligodendrocyte precursor differentiation can be overcome by pharmacological modulation of Fyn-RhoA and protein kinase C signalling
Brain, February 1, 2009; 132(2): 465 - 481.
[Abstract] [Full Text] [PDF]

Home page
 DMMHome page
C. E. Buckley, P. Goldsmith, and R. J. M. Franklin
Zebrafish myelination: a transparent model for remyelination?
Dis. Model. Mech., November 1, 2008; 1(4-5): 221 - 228.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.